Patent · US Active

Crystal forms

USRE48923E1 · kind E1 · reissue

0Cited by
1References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 4, 2017
Grant dateFeb 8, 2022
Priority date
Expiry dateDec 4, 2037

Classification

  • Technology area (CPC —)General

Abstract

The present invention features crystalline forms of Compound I. In one embodiment, a crystalline form of Compound I has characteristic peaks in the PXRD pattern as shown in one of FIGS. 1-10.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.